BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2328133)

  • 1. Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term age.
    Van Geet C; Arnout J; Eggermont E; Vermylen J
    Eicosanoids; 1990; 3(1):39-43. PubMed ID: 2328133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine.
    Hornych A; Krief C; Bariety J
    Prostaglandins Leukot Med; 1982 May; 8(5):467-80. PubMed ID: 6954551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
    Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary 11-dehydro thromboxane B2 during toxemic pregnancies].
    Kobayashi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):715-21. PubMed ID: 1890349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
    Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
    Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11-Dehydro-TXB2 and 2,3-dinor-TXB2 as new parameters of TXA2 generation].
    Katori M; Kawamura M; Sawada M
    Nihon Rinsho; 1992 Feb; 50(2):349-54. PubMed ID: 1613989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator.
    Lorenz RL; Uedelhoven WM; Fischer S; Ruetzel A; Weber PC
    Biochim Biophys Acta; 1989 Dec; 993(2-3):259-65. PubMed ID: 2597697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of canine urinary thromboxanes by GC-MS and HPLC-RIA.
    Tagari P; Callaghan DH; Black C; Yerge JA
    Prostaglandins; 1994 Apr; 47(4):293-306. PubMed ID: 8041872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paired analysis of urinary thromboxane B2 metabolites in humans.
    Catella F; FitzGerald GA
    Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions.
    Vesterqvist O; Gréen K
    Prostaglandins; 1984 Apr; 27(4):627-44. PubMed ID: 6539491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemiluminescent immunoassay for urinary thromboxane B2.
    Morello A; Chang S; Jacob A; Law SJ; Stastny M; Martin L; Pamidi A; Kotake A
    Prostaglandins; 1991 Jul; 42(1):55-70. PubMed ID: 1771240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
    Ciabattoni G; Pugliese F; Davi G; Pierucci A; Simonetti BM; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):66-70. PubMed ID: 2752040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
    Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat.
    Chiabrando C; Corada M; Bachi A; Fanelli R
    Prostaglandins; 1994 Jun; 47(6):409-22. PubMed ID: 7938613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
    Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G
    Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise.
    Rauramo I; Ilmonen S; Viinikka L; Ylikorkala O
    Obstet Gynecol; 1995 Jun; 85(6):1027-30. PubMed ID: 7770249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in urinary immunoreactive-TXB2 and 2,3-dinor TXB2 in man following cardiopulmonary bypass].
    Arima T; Ueda K; Genda T; Omoto R; Matsumoto I; Hori T
    Masui; 1989 Apr; 38(4):512-6. PubMed ID: 2724515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine.
    Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW
    Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.